Generic and therapeutic statin switches and disruptions in therapy

References

• Guidelines for therapeutic interchange. American College of Clinical Pharmacy. Pharmacotherapy 1993;13:252-6
   Google Scholar
• Antman EM, Ferguson JJ. Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents? Circulation 2003;108:2604-7
   PubMed Web of Science ®Google Scholar
• Kereiakes DJ, Willerson JT. Therapeutic substitution: guilty until proven innocent. Circulation 2003;108:2611-12
   PubMed Web of Science ®Google Scholar
• Verispan Vector One National Data. Monthly switch rates in the Lipid Lowering Market Jan-05 through May-07. Custom analysis performed in July 2008 (data on file)
   Google Scholar
• Boston News WCVB investigative report, August 1, 2007. Available at: http://www.thebostonchannel.com/news/13800173/detail.html
   Google Scholar
• Solomont EB. Insurers pay doctors to push generic drugs. New York Sun. July 16, 2008. Available at: http://www.nysun.com/business/insurers-pay-doctors-to-push-generic-drugs/81992/
   Google Scholar
• Taylor AJ, Grace K, Swiecki J, et al. Lipid-lowering efficacy, safety, and costs of a large-scale therapeutic statin formulary conversion program. Pharmacotherapy 2001;21:1130-9
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Maclure M, Dormuth CR, et al. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. Clin Pharmacol Ther 2006;79:379-88
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration Office of Generic Drugs. U.S. Food and Drug Administration website: what are generic drugs? Available at: http://www.fda.gov/cder/ogd/index.htm Introduction [Last accessed 9 June 2008]
   Google Scholar
• Mignini F, Tomassoni D, Streccioni V, et al. Pharmacokinetics and bioequivalence study of two tablet formulations of lovastatin in healthy volunteers. Clin Exp Hypertens 2008;30:95-108
   PubMed Web of Science ®Google Scholar
• Assawawitoontip S, Wiwanitkit V. A randomized crossover study to evaluate LDL-cholesterol lowering effect of a generic product of simvastatin (Unison Company) compared to simvastatin (Zocor) in hypercholesterolemic subjects. J Med Assoc Thai 2002;85 (Suppl. 1):S118-24
   PubMedGoogle Scholar
• Fox KM, Gandhi SK, Ohsfeldt RL, et al. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting. Am J Manag Care 2007;13 (Suppl. 10):S270-5
   PubMed Web of Science ®Google Scholar
• Krasuski RA, Doeppenschmidt D, Henry JS, et al. Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH study. Mayo Clin Proc 2005;80:1163-8
   PubMed Web of Science ®Google Scholar
• Raal FJ. A single-centre retrospective observational study to evaluate the change in total cholesterol and LDL cholesterol in hyperlipidaemic patients switched from atorvastatin to simvastatin. Cardiovasc J S Afr 2004;15:118-23
   PubMedGoogle Scholar
• Rindone JP, Arriola G. Conversion from fluvastatin to simvastatin therapy at a dose ratio of 8 to 1: effect on serum lipid levels and cost. Clin Ther 1998;20:340-6
   PubMed Web of Science ®Google Scholar
• Rindone JP, Arriola G, Hiller D, et al. Changes in serum lipids when fluvastatin is substituted for lovastatin in the same doses. Am J Cardiol 1997;80:348-9
   PubMed Web of Science ®Google Scholar
• Usher-Smith J, Ramsbottom T, Pearmain H, et al. Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on. Int J Clin Pract 2008;62:480-4
   PubMed Web of Science ®Google Scholar
• Usher-Smith JA, Ramsbottom T, Pearmain H, et al. Evaluation of the cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a Primary Care setting. Int J Clin Pract 2007;61:15-23
   PubMed Web of Science ®Google Scholar
• Schuster H, Barter PJ, Stender S, et al. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study. Am Heart J 2004;147:705-13
   PubMed Web of Science ®Google Scholar
• Phillips BRC, Rudolph AE, Morant S, et al. Switching statins: the impact on patient outcomes. Br J Cardiol 2007;14:280-5
   Google Scholar
• Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:462-7
   PubMed Web of Science ®Google Scholar
• Ridley DB, Axelsen KJ. Impact of Medicaid preferred drug lists on therapeutic adherence. Pharmacoeconomics 2006;24 (Suppl. 3):65-78
   PubMed Web of Science ®Google Scholar
• Minhas R, Bogle RG, Patel KC, et al. Pharmacopolitics, statin switching and therapeutic substitution: much ado about something. Int J Clin Pract 2008;62:354-5
   PubMed Web of Science ®Google Scholar
• Atar D, Carmena R, Clemmensen P, et al. Clinical review: impact of statin substitution policies on patient outcomes. Ann Med 2009;4:1-15
   Google Scholar
• Joyce AT, Harrison DJ, Loebel AD, et al. Impact of atypical antipsychotics on outcomes of care in schizophrenia. Am J Manag Care 2005;11:S254-61
   PubMed Web of Science ®Google Scholar
• Penning-van Beest FJ, Termorshuizen F, Goettsch WG, et al. Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study. Eur Heart J 2007;28:154-9
   PubMed Web of Science ®Google Scholar
• Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation 2000;101:207-13
   PubMed Web of Science ®Google Scholar
• Illingworth DR, Tobert JA. A review of clinical trials comparing HMG-CoA reductase inhibitors. Clin Ther 1994;16:366-85; discussion 365
   PubMed Web of Science ®Google Scholar
• Aitken M, Berndt ER, Cutler DM. Prescription drug spending trends in the United States: Looking beyond the turning point. Health Affairs 2008;28:w151-60
   Web of Science ®Google Scholar
• Druss BG, Marcus SC, Olfson M, et al. Listening to generic Prozac: winners, losers, and sideliners. Health Affairs 2004;23:210-16
   Web of Science ®Google Scholar
• Speedy switch to generic Prozac. Medical Marketing & Media. Sept. 2001. Available at: http://findarticles.com/p/articles/mi_qa5351/is_/ai_n21477915?tag=artBody;col1
   Google Scholar